JohnMuraski, Jr.MDPhD(He/Him)

PubMed

• 26 citations
  De Novo Design of Skin-Penetrating Peptides for Enhanced Transdermal Delivery of Peptide Drugs
  Stefano Menegatti, Michael Zakrewsky, Sunny Kumar, Joshua Sanchez De Oliveira, John A. Muraski
  Advanced Healthcare Materials. 2016-03-01
• 2 citations
  Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.
  Sunny Kumar, Ming Chen, Aaron C. Anselmo, John A. Muraski, Samir Mitragotri
  Drug Delivery and Translational Research. 2015-05-05
• 34 citations
  Topical delivery of Cyclosporine A into the skin using SPACE-peptide.
  Ming Chen, Sunny Kumar, Aaron C. Anselmo, Vivek Gupta, Deborah H. Slee
  Journal of Controlled Release. 2015-02-10

Journal Articles

• Elderly Man with Abdominal Pain: ACE-inhibitor Induced Gastrointestinal Angioedema  
  Muraski JA, Emmanuel GN, Annals of Emergency Medicine, 6/2019
• Mechanistic analysis of cellular internalization of a cell and skin penetrating peptide.  
  Zakrewsky M, Muraski JA, Mitragotri S, Regenerative Engineering and Translational Medicine, 3/2016

Books/Book Chapters

• The Cardioprotective Effects of Pim-1 Kinase 
  Muraski JAUniversity of California San Diego, San DiegoEdition 1,2007

Abstracts/Posters

• Targeted nanoparticle-based therapy for the treatment of glioblastoma multiforme: Unprecedented anti-cancer activity in highly drug resistant/refractory mouse models o...
  6. Hudson S, Agemy L, Kotamraju VR, Sharma S, Ruoslahti E, Brunel F, MacLaren A, Muraski J, Slee D, AACR Annual Meeting 2014, San Diego, CA, 4/2014
• Pim-1 stimulates cardiac progenitor cell proliferation and asymmetric division.
  Cottage TC, Tuck S, Fischer K, Gude N, Muraski J, Sussman MA., American Heart Association, Scientific Sessions, New Orleans, LA, 11/2008
• Formation of temporary niches is required for bone marrow cells to adopt the cardiomyogenic fate in vivo
  Rota M, Kajstura J, Hosada T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas E, Gonzalez A, Rizzi R, Small N, Muraski J, Chan X, Urbanek K, Bolli R, House..., American Heart Association, Scientific Sessions, Melvin L. Marcus Young Investigator Award, Orlando, FL, 11/2007
• Activation of notch-mediated protective signaling in the myocardium
  Gude N, Emmanuel G, Wu W, Cottage CT, Fischer K, Quijada P, Muraski JA, Alvarez R, Rubio M, Schaefer E, Sussman MA, Keystone Symposium on Stem Cells, Keystone, CO, 7/2007
• Pim-1 regulates cardiomyocyte survival downstream of Akt
  Muraski JA, Fransioli J, Gude N, Alvarez R, Cottage C, Siddiqi S, Martindale J, Glembotski CC, Magnuson N, Berns A, Houser D, Schaefer E, Sussman MA, American Heart Association, Scientific Sessions;, Chicago, IL, 11/2006
• Join now to see all

Lectures

• Altered mental status and tonic-clonic seizures in a patient after hip joint prosthesis explantation. 
  Clinical Neurology Continuing Medical Education Course, St. Vincent Medical Center - 11/13/2018
• 21st Century Drug Development: The SPACE peptide paradigm 
  College of Pharmacy, Department of Pharmacology & Toxicology, University of Arizona - 2/2015
• Convoy Therapeutics: a paradigm shift in transdermal drug delivery 
  White Hat Investors Forum, Phoenix, AZ - 10/2014
• Convoy Therapeutics: a paradigm shift in transdermal drug delivery 
  Rocky Mountain Life Sciences Investor and Partnering Conference, Vail, CO - 9/2014
• Convoy Therapeutics: a paradigm shift in transdermal drug delivery 
  Family Office and Investment Conference; Geneva, Switzerland - 6/2014
• The ACTUS Story; A new bioaccelerator model for the age of biotechnology 
  Bioindustry Organization of Southern Arizona - 3/2014
• Targeting neoplasms and atherosclerosis using novel targeted-nanoworm constructs 
  Partnerships in Drug Delivery; Boston, MA - 10/2013
• Convoy Therapeutics; altering the topical treatment paradigm 
  Partnerships in Drug Delivery; Boston, MA - 10/2013
• The new FDA regulatory environment and its effect on medical device approvals 
  BioConference Live; Irvine, CA - 8/2010
• The development and characterization of transgenic and gene targeted animal models 
  California Lutheran University; Thousand Oaks, CA - 4/2003
• Join now to see all

Other

• Compositions and method for manipulating pim-1 activity in circulatory system cells 
  Muraski JA, Sussman MA, USPTO Application Number: 19/0060417A1
  2/2019
• Skin penetrating peptides (spps) and methods of use therefor 
  Muraski JA, Mitragotri S, Chen M, Application Number: WO 2016033314A1
  6/2016
• Skin permeating and cell entering (space) peptides and methods of use therefor 
  Muraski JA, Mitragotri S, Kumar S, Application Number: PCT/US2013/025543
  2/2013
• Composition and methods for operating the pim-1 activity in circulatory system cells 
  Muraski JA, Sussman MA, JPPTO Application Number: JP2011-503207A
  1/2011
• Join now to see all